Literature DB >> 2358844

Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique.

A P Bowles1, C G Pantazis, W Wansley, M B Allen.   

Abstract

This report describes a new fluorescent microcarrier cytostasis assay. Human glioma cell lines and primary cultures were attached to microcarrier tissue culture beads and treated with various chemotherapeutic drugs. After treatment, the cells were labelled with two vital fluorescent dyes in order to measure cellular viability. The uptake of hydroethidine and Hoechst 33342 was evaluated alone and in combination as probes for determining metabolic activity and cellular proliferation. Hydroethidine was found to be superior when compared to trypan blue and tritiated thymidine. The use of the microcarrier technique allows for the direct cellular measurement of fluorescence without the need of extensive extraction procedures. The fluorescent assay is a sensitive, rapid and an effective way to screen for potential antiproliferative compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358844     DOI: 10.1007/bf00177832

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Characterization of a novel reaction by human O6-alkylguanine-DNA alkyltransferase with 1,3-bis(2-chloroethyl)-1-nitrosourea-treated DNA.

Authors:  T P Brent; J S Remack; D G Smith
Journal:  Cancer Res       Date:  1987-12-01       Impact factor: 12.701

2.  Tissue-culture microtest for predicting response of human cancer to chemotherapy.

Authors:  H L Holmes; J M Little
Journal:  Lancet       Date:  1974-10-26       Impact factor: 79.321

3.  The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  B Drewinko; J K Novak; S C Barranco
Journal:  Cancer Res       Date:  1972-06       Impact factor: 12.701

4.  Analysis and sorting of living cells according to deoxyribonucleic acid content.

Authors:  D J Arndt-Jovin; T M Jovin
Journal:  J Histochem Cytochem       Date:  1977-07       Impact factor: 2.479

5.  Development of a clonogenic cell assay for human brain tumors.

Authors:  M L Rosenblum; D A Vasquez; T Hoshino; C B Wilson
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

6.  BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.

Authors:  M D Walker; B S Hurwitz
Journal:  Cancer Chemother Rep       Date:  1970-08

7.  Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.

Authors:  Y Noso; K Niimi; M Nishiyama; N Hirabayashi; T Toge; M Niimoto; T Hattori
Journal:  Cancer Res       Date:  1987-12-01       Impact factor: 12.701

8.  The physiological disposition of the carcinostatic 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in man and animals.

Authors:  V T DeVita; C Denham; J D Davidson; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1967 Jul-Aug       Impact factor: 6.875

Review 9.  Chemotherapy for malignant gliomas.

Authors:  P L Kornblith; M Walker
Journal:  J Neurosurg       Date:  1988-01       Impact factor: 5.115

10.  Modulation of interleukin-1 activity on murine thymocytes by various inhibitors of arachidonic acid oxygenation.

Authors:  R M Schultz; M G Altom
Journal:  Immunopharmacol Immunotoxicol       Date:  1988       Impact factor: 2.730

View more
  2 in total

Review 1.  Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth.

Authors:  Jacek Zielonka; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

Review 2.  Apoptosis in glioma cells: review and analysis of techniques used for study with focus on the laser scanning cytometer.

Authors:  Bardia Amirlak; William T Couldwell
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.